Search Results 11-20 of 17064 for intestinal metaplasia
-
Treatment with RFA and resection can reduce the risk of cancer progression and induce complete remission of intestinal metaplasia (CRIM), both endoscopically ...
-
Patients that have not achieved complete remission of intestinal metaplasia. Patients unable to consent. Pregnant women. Participating Mayo Clinic locations.
-
This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...
-
Recurrence of intestinal metaplasia and dysplasia after complete endoscopic eradication therapy (EET) of dysplasia or early adenocarcinoma is well documented.
-
Known or suspected gastrointestinal cancers, such as stomach, small bowel, colon or rectal cancer. ... Gastric intestinal metaplasia. Lymphoma of colon or rectum.
-
Known or suspected gastrointestinal cancers, such as stomach, small bowel, colon or rectal cancer. ... Gastric intestinal metaplasia. Lymphoma of colon or rectum.
-
... intestinal metaplasia following endoscopic ablation. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...
-
... intestinal metaplasia, dysplasia, or EAC versus patients who achieved complete remission for at least > 1 year following initial endoscopic intervention ...
-
... intestinal metaplasia (IM) in the tubular esophagus after 3 or more radiofrequency ablations (RFA) for dysplastic BE, or <50% eradication of Barrett's ...
-
Surgery or endoscopy procedures to correct a hiatal hernia or to tighten the lower esophageal sphincter that controls the flow of stomach acid may be an option.